Thermo Fisher Acquires Gatan in $925M Sale

Thermo Fisher Acquires Gatan in $925M Sale

Firm News

Related Solutions

Lawyers with deep and broad experience counseling clients in every industry on the design, implementation, and interpretation of executive compensation arrangements and on general compensation and benefits issues.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
WilmerHale is renowned for its sophisticated representation of investors, developers, landlords, tenants, lenders and institutions on complex real estate projects and transactions.

Thermo Fisher Scientific, Inc., a multinational biotechnology product development company, and Roper Technologies, Inc., a leading diversified technology company, announced on June 28, 2018, that they have entered into a definitive agreement under which Thermo Fisher will acquire Gatan, Inc., a wholly owned subsidiary of Roper, for approximately $925 million.

The WilmerHale team advising Thermo Fisher in the acquisition is led by Hal Leibowitz and includes Keith Barnett, Andrew Bonnes, Robert Burke, Joseph Conahan, Jeff Johnson, Scott Kilgore, Amy Null, Ciara Baker, Elizabeth Mayo, Morgan Monroe and Alan Wilson.

Read Thermo Fisher’s press release about the acquisition.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel